Impact of thoracic radiotherapy on first‐line treatment outcomes in <scp>ES</scp>‐<scp>SCLC</scp> patients
Thus, weconfirmed that the addition of tRT to the conventional regimen of first-linechemotherapy and immunotherapy yields better survival outcomes without asignificant increase in toxicity.
Authors
- Ke Wang (ORCID: https://orcid.org/0000-0003-1030-0288)
- Panwen Tian (ORCID: https://orcid.org/0000-0002-6313-3228)
- Qing Liu (ORCID: https://orcid.org/0000-0002-9430-8238)
- Feng Xu (ORCID: https://orcid.org/0000-0003-0902-2858)
- Jiantao Wang (ORCID: https://orcid.org/0000-0002-0501-6488)
- Yan Zhang (ORCID: https://orcid.org/0000-0001-8738-2053)
- Li Lu (ORCID: https://orcid.org/0000-0002-8956-8924)
- Jiewei Liu (ORCID: https://orcid.org/0009-0009-8265-8984)
- Yalun Li (ORCID: https://orcid.org/0000-0002-6977-1626)
- Yixin Zhou (ORCID: https://orcid.org/0000-0001-5443-4582)
- Yan Li (ORCID: https://orcid.org/0000-0001-8105-3072)
- Jiyan Liu (ORCID: https://orcid.org/0000-0003-4885-5481)
- Feng Luo (ORCID: https://orcid.org/0000-0003-4008-271X)
- Xiaoli Mu
Institutions
- Sichuan University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/cam4.70175
- Citations
- 6
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- Sichuan University
- Chinese Academy of Medical Sciences
- Wu Jieping Medical Foundation
- Sichuan Province Science and Technology Support Program
- West China Hospital, Sichuan University